Brinda Balakrishnan - Net Worth and Insider Trading
Brinda Balakrishnan Net Worth
The estimated net worth of Brinda Balakrishnan is at least $142,988 dollars as of 2024-11-13. Brinda Balakrishnan is the Director of Aurinia Pharmaceuticals Inc and owns about 17,523 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $142,988. Details can be seen in Brinda Balakrishnan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brinda Balakrishnan has not made any transactions after 2024-05-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brinda Balakrishnan
Brinda Balakrishnan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brinda Balakrishnan owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Brinda Balakrishnan’s form 4 insider trades.
Insider Ownership Summary of Brinda Balakrishnan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | director |
Brinda Balakrishnan Latest Holdings Summary
Brinda Balakrishnan currently owns a total of 1 stock. Brinda Balakrishnan owns 17,523 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 21, 2024, with a value of $142,988.
Latest Holdings of Brinda Balakrishnan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-05-21 | 17,523 | 8.16 | 142,988 |
Holding Weightings of Brinda Balakrishnan
Brinda Balakrishnan Form 4 Trading Tracker
According to the SEC Form 4 filings, Brinda Balakrishnan has made a total of 1 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 520 shares on May 21, 2024, which brought Brinda Balakrishnan around $2,985.
Insider Trading History of Brinda Balakrishnan
- 1
Brinda Balakrishnan Trading Performance
Brinda Balakrishnan Ownership Network
Ownership Network List of Brinda Balakrishnan
Ownership Network Relation of Brinda Balakrishnan
Brinda Balakrishnan Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Brinda Balakrishnan is the director of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Brinda Balakrishnan made no insider transaction in Aurinia Pharmaceuticals Inc (AUPH). Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 13,679 shares made by Jayne David R.w. .
In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 9,798 shares. During the past 18 months, 397,215 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,215 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Brinda Balakrishnan Mailing Address
Above is the net worth, insider trading, and ownership report for Brinda Balakrishnan. You might contact Brinda Balakrishnan via mailing address: #1203-4464 Markham Street, Victoria A1 V8z7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
